What's breaking now, across thousands of outlets.
TEV ‘408 met its main Phase 2a goal, cutting intestinal damage and inflammation during six weeks of daily gluten exposure, with no safety signals observed to date
We haven't written up this one. Ynetnews Culture has the full story — the link below goes straight to it.
More than six years after the pandemic arrived and ivermectin and hydroxychloroquine were first touted as COVID cures, the evidence shows more than ever that they don't work.
We deal with a seemingly endless conveyor belt of fad quack remedies (the proverbial game of whack-a-mole). We always have some new nonsense to deal with.
A new study has found a strong association between mobile gaming addiction and musculoskeletal pain, with addicted students more than three times as likely to report neck pain and more than four times…
Analysts warn a disruption in Chinese sources of common antibiotics or blood thinners could leave American patients with no reliable alternative.
It offers a "safe way to target chemo resistant tumors," the study's author Ozgur Sahin told Newsweek.
Daniel Chojnowski, JHHP’s current CFO, will provide stability so that the Baltimore-area insurer can recruit full-time for its next chief executive, the company said.
